May 22, 2026 · Form 4 insider transaction
Lezack Adam sold 998 shares of Beta Bionics, Inc. at $11.21 per share, a transaction worth $11.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025.